Fluorouracil irinotecan companion diagnostic - Everist GenomicsAlternative Names: OncoDefender-CRC; OncoSelector
Latest Information Update: 19 Mar 2012
At a glance
- Originator Everist Genomics
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Colorectal cancer
Most Recent Events
- 14 Mar 2012 Launched for Colorectal cancer (diagnosis) in USA (unspecified route)